Johnson & Johnson subsidiaries

Neutrogena the #1 Dermatologist Recommended skincare brand offers a wide range of skin and hair care products. Neutrogena.com is your online destination for great values, special offers, and the latest news on some of the world's most loved beauty and skincare products.

Biosense Webster, Inc. is the global leader in the science of diagnosing and treating heart rhythm disorders. The company partners with clinicians to develop innovative technologies that improve the quality of care for arrhythmia patients worldwide. Biosense Webster is part of the Johnson & Johnson Family of Companies. More information can be found at www.biosensewebster.com.

Alza Corporation was a pharmaceutical and medical systems company.

Scios Inc. is a pharmaceutical company developing drugs for the treatment of cardiovascular and inflammatory diseases. The company is a subsidiary of Johnson & Johnson. The company's portfolio of drugs includes NatrecorO, a promising drug for heart failure. Scios Inc. was founded in 1981 and is based in California.

SterilMed, Inc. reprocesses, remanufactures, and repairs medical devices and equipment. The company offers its repair services for a range of medical equipment, including flexible and rigid endoscope systems, camera and video tower systems, power equipment, surgical instrumentation products. It also engages in the sale of pre-owned medical equipment, including flexible and rigid endoscopes, power equipment, cameras, and support equipment; and surgical video equipment and accessories, which include camera consoles, carts, electrosurgical units, insufflators, light sources, monitors, printers processors, pumps, ultrasonic cleaners/scope washers video recorders, and video scope cables. The company was founded in 1997 and is based in Maple Grove, Minnesota. SterilMed, Inc. operates as a subsidiary of Johnson & Johnson.

OptiMedica Corporation is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. The company was founded in 2004 with the vision of bringing innovative new technologies to ophthalmologists and transforming existing standards of care. Since its founding, OptiMedica has been developing a reproducible, noninvasive technique to replace the inconsistent manual steps in cataract surgery with femtosecond laser technology. The system has been designed to deliver new levels of precision, control, performance, and efficacy to cataract surgeons and their patients. OptiMedica has completed clinical trials of its Catalys™ Precision Laser System, with very promising results reported across these measures. While the Catalys Precision Laser System is not currently for sale in the United States, OptiMedica expects to launch the system in U.S. and international markets in 2011.

Cotherix is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. Ventavis, our lead product candidate, is an inhaled formulation of iloprost.

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

At Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division (McNeil), their roots in over-the-counter (OTC) medicine run deep. In 1879, Robert McNeil founded his pharmacy as a local business supplying medications to Philadelphia hospitals and doctors. Since this time, they have grown to become a company whose products are known and trusted by people around the world. McNeil markets a broad range of well-known and trusted OTC products around the globe. They are most widely recognized for the complete line of TYLENOL acetaminophen products, the leading brand of pain reliever/fever reducer in the adult and pediatric categories. The TYLENOL product line consists of products across a variety of pain categories including: arthritis pain, pain with accompanying sleeplessness and symptoms of cold and flu. Other McNeil brands include BENADRYL , ZYRTEC and ZYRTEC-D allergy medicines; IMODIUM anti-diarrheal products; MOTRIN IB; SUDAFED and SUDAFED PE nasal decongestants.

Noramco was formed in 1979 to design, construct and manage a bulk active pharmaceutical ingredient plant in Wilmington, Delaware to support Ortho-McNeil Pharmaceutical's Tylenol with codeine business. With the acquisition of Tasmanian Alkaloids and addition of the Athens, Georgia site in 1982, and continuous expansions over the past three decades at both US facilities, Noramco now contributes to billion dollar affiliate franchises, as well as to significant 3rd party generic and branded pharmaceutical products worldwide.